Breaking News, Promotions & Moves

TCR2 Therapeutics Appoints Chief Technical Officer

Peter Olagunju to oversee process development, manufacturing, quality control and technical operations for the company’s TRuC-T cell programs.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

TCR2 Therapeutics Inc., a clinical-stage cell therapy company, appointed Peter Olagunju as Chief Technical Officer to oversee process development, manufacturing, quality control and technical operations for the company’s TRuC-T cell programs and emerging pipeline.   Mr. Olagunju brings more than 20 years of experience in cell and gene therapy, clinical development, program management, manufacturing and technical operations. Prior to joining the company, he was Senior Vice President of Technica...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters